The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...
But on Thursday, March 27, the U.S. Consumer Product Safety Commission (CPSC) announced a nationwide recall on “about 17,660” ...
The effect of saccharin on the microbiome has received much attention, but its impact on pathogenic bacterial species is less ...
An exotic state of matter has been found lurking within a previous exotic state which had discovered in a magnetic compound ...